Paper12922
A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia.
Paprocki J and 1 other. Curr Ther Res Clin Exp, 1977. Cited by 50 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia. Papers, record 12922. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12922
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dibenzoxazepines | Major topic |
| Haloperidol | Major topic |
| Loxapine | Major topic |
| Schizophrenia | Major topic |
| Acute Disease | |
| Adolescent | |
| Adult | |
| Aggression | |
| Brief Psychiatric Rating Scale | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Injections, Intramuscular | |
| Psychiatric Status Rating Scales | |
| Sleep | |
| Time Factors |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,129,067 | Diagnosis and Medication Treatment of Schizophrenia in Adolescents. | Drugs | 2026 | https://conductscience.org/library/papers/42129067 | PubMed |
| 28,758,203 | Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). | Cochrane Database Syst Rev | 2017 | https://conductscience.org/library/papers/28758203 | PubMed |
| 27,022,468 | Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study. | Pharmacol Res Perspect | 2015 | https://conductscience.org/library/papers/27022468 | PubMed |
| 25,859,275 | Revisiting loxapine: a systematic review. | Ann Gen Psychiatry | 2015 | https://conductscience.org/library/papers/25859275 | PubMed |
| 25,808,074 | Multiple dose pharmacokinetics of inhaled loxapine in subjects on chronic, stable antipsychotic regimens. | J Clin Pharmacol | 2015 | https://conductscience.org/library/papers/25808074 | PubMed |
| 25,592,299 | Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/25592299 | PubMed |
| 24,745,666 | Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials. | J Aerosol Med Pulm Drug Deliv | 2014 | https://conductscience.org/library/papers/24745666 | PubMed |
| 23,739,987 | Brain disposition and catalepsy after intranasal delivery of loxapine: role of metabolism in PK/PD of intranasal CNS drugs. | Pharm Res | 2013 | https://conductscience.org/library/papers/23739987 | PubMed |
| 17,943,763 | Loxapine for schizophrenia. | Cochrane Database Syst Rev | 2007 | https://conductscience.org/library/papers/17943763 | PubMed |
| 25,167 | Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent. | Drugs | 1978 | https://conductscience.org/library/papers/25167 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12922
GET https://conductscience.org/api/papers/v1/12922/authors